CDH2 and cancer: Epithelial-mesenchymal transition (EMT) and inhibition of Wnt/β-catenin signalling pathway contribute to migratory potential of cancer cells, alongside with overexpression of promigratory/invasive proteins: N-cadherin, Snail, vimentin, and β-catenin (4, 5).